JUST IN: The FDA announced a proposed ban on menthol cigarettes and all flavors in cigars, a move that could further drive down smoking rates in the U.S.
The Food and Drug Administration announced on Thursday a proposed ban on menthol cigarettes and all flavors in cigars, a move that could further drive down smoking rates in the U.S.
. In the U.S., menthol cigarettes represent over a third of cigarette sales, with almost 19 million users. Black Americans have disproportionately high rates of menthol smoking, a consequence of years of racially targeted advertising.according to the FDA
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Announces Recall of Popular Blood Pressure Medication Due to Potential Cancer RiskIt’s time to double-check your medicine cabinets.
Read more »
FDA Approves First COVID Treatment for Use in KidsThe FDA has approved the antiviral remdesivir as the first COVID-19 treatment for young children.
Read more »
Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11Pfizer and BioNTech said Tuesday that they have submitted an application to the US Food and Drug Administration for emergency use authorization of a booster dose of Covid-19 vaccine for children 5 through 11.
Read more »
Pfizer Asks FDA to Authorize Third Dose for Children 5 to 11 Years OldPfizer on Tuesday asked the Food and Drug Administration to authorize a third dose of its COVID vaccine for children ages 5- to 11-years-old. The application comes after Pfizer released data earlier this month from a small lab study of blood samples from 30 kids in the age group, which showed a 36-fold increase in antibody levels against the omicron variant…
Read more »
Pfizer asks FDA to authorize COVID booster for children 5 to 11If approved, it would be the first booster accessible to children of this age group, who were hit hard by Omicron.
Read more »
Pfizer Asks FDA to Authorize Covid-19 Booster for 5- to 11-Year-OldsPfizer Inc. and partner BioNTech SE said earlier this month that a third shot safely generated a strong immune response in the youngsters.
Read more »